Related Articles
Targeted chemotherapy for triple-negative breast cancers via LHRH receptor
Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers
Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line.
Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro